Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer explores sale of hospital drugs unit, sources say
Exclusive: Pfizer explores sale of hospital drugs unit, sources say
Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
Pfizer reportedly eyeing sale of hospital drugs unit
Pfizer
(NYSE:PFE) has hired Goldman Sachs to gauge initial buyer interest as part of an attempt to sell its hospital drugs unit,
Pfizer
Hospital, potentially worth a few billion dollars, Reuters reported Tuesday, citing three people familiar with the matter.
Pfizer said to be exploring sale of hospital drugs unit, Reuters reports
Pfizer
(PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, Reuters’ Anirban Sen reports, citing people familiar with the matter.
FiercePharma
1d
Pfizer explores sale of hospital drugs unit amid activist investor’s call for accountability: Reuters
After a series of acquisitions and an activist investor’s accusation of overspending,
Pfizer
is exploring an opportunity to ...
STAT
1d
How Pfizer used wearables to tap into the promise of an experimental drug
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
2d
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
devdiscourse
2h
Pharma Updates: Amgen Overcomes Concerns, AstraZeneca Expands, and Pfizer Considers Sale
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
FierceBiotech
1d
Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
6d
3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
18h
Keurig Dr Pepper hires ex-Pfizer CMO to lead beverage marketing
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
4d
on MSN
Pfizer Inc. (PFE): Among the Best Low Volatility Stocks to Invest In Now
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
21h
Pfizer exploring sale of hospital drugs unit, Reuters reports
Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for ...
The Business Journals
15h
Potential sale of Pfizer unit could include massive North Carolina facility
Pfizer
is reportedly considering selling one of its business units that has major operations in North Carolina STORY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
China
AstraZeneca
India
Meenakshi Nevatia
Feedback